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Abstract
Background: Leptospirosis is a global zoonotic disease. Although important for the assessment of the burden of
leptospirosis, data on the duration of the illness and the occurrence of post-leptospirosis complaints are not well
documented. Hence the main objective of this study was to estimate the occurrence of persistent complaints and
duration of hospital stay in laboratory confirmed leptospirosis patients in the Netherlands during 1985 to 2010.
Additionally, several risk factors potentially impacting on the occurrence of post-leptospirosis complaints were
investigated.
Methods/Principal Findings: The duration of the acute phase of leptospirosis was 16 days (IQR 12–23); 10 days
(IQR 7–16) were spent hospitalized. Eighteen fatal cases were excluded from this analysis. Complaints of
leptospirosis patients by passive case investigations (CPC) derived from files on ambulant consultations occurring
one month after hospital discharge, revealed persistent complaints in 108 of 236 (45.8%) laboratory confirmed cases.
Data on persistent complaints after acute leptospirosis (PCAC), assessed in 225 laboratory confirmed leptospirosis
cases collected through questionnaires during 1985-1993, indicated 68 (30.2%) PCAC cases. Frequently reported
complaints included (extreme) fatigue, myalgia, malaise, headache, and a weak physical condition. These complaints
prolonged in 21.1% of the cases beyond 24 months after onset of disease. There was no association between post-
leptospirosis complaints and hospitalization. However, individuals admitted at the intensive care unit (ICU) were twice
as likely to have continuing complaints after discharge adjusting for age and dialysis (OR 2.0 95% CI 0.8-4.8). No
significant association could be found between prolongation of complaints and infecting serogroup, although
subgroup analysis suggest that infection with serogroups Sejroe (OR 4.8, 95%CI 0.9-27.0) and icterohaemorrhagiae
(OR 2.0, 95%CI 0.9-4.3 CI) are more likely to result in CPC than infections with serogroup Grippotyphosa.
Conclusion/Significance: In addition to the acute disease, persistent complaints have an impact on the burden of
leptospirosis.
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Introduction
Leptospirosis is a zoonotic disease with worldwide
distribution [1]. Human leptospirosis is a neglected and
underreported disease [2], due to a lack of awareness,
misdiagnosis and technically demanding laboratory
confirmation tests [2,3]. Recent international initiatives on the
assessment of the global disease burden of leptospirosis have
estimated the global annual incidence of endemic human
leptospirosis exceeding 5 severe cases per 100.000
population, excluding cases from outbreaks [2]. However, this
number probably presents a substantial underestimation; as
this incidence is derived from underreported, laboratory
confirmed cases. The true total incidence of mild and severe
leptospirosis most likely presents only a small portion of the
true number of mild to severe cases annually.
Leptospirosis is caused by pathogenic spirochaetes of the
genus Leptospira [4]. A wide variety of mammalian hosts, both
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feral and (semi-) domestic, serve as infection reservoirs. In
developing countries, urban leptospirosis is an increasing
public health hazard due to hygiene and overcrowding issues,
however, farmers still represent the major risk group for
leptospirosis [5]. In developed, temperate countries
leptospirosis is mainly a recreational disease, associated with
water-contact activities [1,2].
Leptospirosis is a protean disease ranging from a sub-clinical
illness to a potentially fatal disease with haemorrhage and
multi-organ failure as its clinical hallmarks. Persistent or
chronic symptoms are often variable in character and onset [6].
This complicates the association between acute disease and
sequelae [6,7] and makes it difficult to truly measure the
burden of disease. Apart from some anecdotal case reports,
post-leptospirosis complaints are not well assessed [3]. Data
on the impact and occurrence of persistent or chronic
complaints, together with data on the period of hospitalization
are badly needed for assessing the burden of leptospirosis in
terms of disability-adjusted life years (DALYs) [2,3].
Therefore, in this paper we describe the estimate of the
burden of hospitalized and outpatient human leptospirosis in
The Netherlands with regard to the duration of the acute and
chronic illness as well as the incidence of persistent symptoms
by active and passive case finding. We estimate the effect of
intensive care unit (ICU) stay adjusted for the potential
confounding effect of age, gender, infecting serogroup and
occurrence of the acute severe complications of lung (acute
lung injury, (ALI)) and kidney (acute renal injury (ARI)), liver
injury and haemorrhage. As well, several studies have shown
that ICU admission is a risk factor for both physical and
psychological symptoms up to 12 months after discharge from
the hospital [8]. Psychological consequences include
depressive symptoms, post-traumatic stress disorders (PTSD),
anxiety and chronic fatigue syndrome (CFS). These sequelae
were associated with traumatic memories during ICU or
hospital stay [9–11]. In the light of these studies regarding
persistent symptoms, in this study it was considered of
particular importance, to determine whether there is an
association between ICU stay and persistent symptoms after
the acute phase of leptospirosis.
Methods
Ethical statement
The Medical Ethical Review Committee of the Academic
Medical Center, University of Amsterdam provided clearance
for the execution of the active survey on persistent complaints
(96.17.038). In addition, the Medical Ethical Review Committee
waived the study for human subjects research ethical review
for the data collected from passive case finding
(W12_075#12.17.0092). All presented data have been de-
identified and are not attributable to individual patients.
Study participants and data collection
The WHO/FAO/OIE and National Leptospirosis Reference
Center (NRL) resides in the department of Biomedical
Research of the Royal Tropical Institute in Amsterdam, The
Netherlands. NRL forms the diagnostic center for leptospirosis
in the Netherlands, confirming nearly 100% of the cases
suspected of leptospirosis in the country. Confirmation was
done in accordance with the national laboratory case definition
[12], which is consistent with the definition of the WHO-
Leptospirosis Epidemiology Reference Group (LERG) [2].
From 1985 until 2010 the laboratory received an estimated
20,000 samples for investigation. Detailed records on
serological, clinical and epidemiological data, including letters
of discharge and ambulant consultations after discharge from
the hospitals are archived in the NRL. Abstracted data from this
archive were used to assess post-leptospirosis complaints by
active and passive case finding (see below), duration of illness,
hospitalization and attendance of the ICU. Data on the health
status of the general population in the Netherlands were
retrieved from the Dutch Central Bureau for Statistics (CBS).
Persistent Complaints by Active Case finding
In 1997 an active survey on long-term persistent symptoms
among leptospirosis confirmed patients was conducted.
Questionnaires were sent to the general practitioners (GP) of
all confirmed cases from the years 1985 to 1993. Complaints
derived from the questionnaires are referred to as Persistent
Complaints by Active Case finding (PCAC) and comprises both
hospitalized patients and outpatients. The following questions
were included in the questionnaire: (i) Did the patient have
long-term complaints after the acute disease? (ii) If so, what
were the complaints? (iii) What was the duration of these
complaints?
Complaints determined by Passive Case finding
Complaints by passive case (CPC) finding were collected
from all hospitalized leptospirosis patients from 1985 to 2010
that were confirmed by NRL. Archived data [13] included
information on symptoms and signs, including those from
ambulant consultations. These were usually collected one
month after patient discharge from the hospital. For the
purpose of determining continued reported complaints following
hospital discharge this data was compiled, entered and
analysed.
Data processing and definitions
Fatality was used as an exclusion criterion in the analyses
for several reasons; firstly, progression towards death is
usually rapid and not a good indicator for the mean duration of
a stay in the hospital and secondly, death itself is a major
burden factor.
The total acute phase of illness is defined as the first day of
illness till the day of discharge from the hospital, which includes
the date of discharge. The total acute phase of illness was
separated into number of days prior to hospital admission and
number of days of hospital stay. ICU stay was defined as the
first day of admittance to discharge from ICU. If either of these
dates were missing, ICU stay was recorded as yes, but the
length of time was not calculated and recorded as missing.
Cases with incomplete data affecting a specific evaluation (for
example, lacking data on the duration of hospital stay) were
excluded only from the part of the analyses. Also,
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questionnaires that contained conflicting or incomplete
information were excluded from the analyses.
Other factors that were included in the analyses were gender
and age (<38 years; ≥38 years) in which 38 years of age was
the median age in the study population during the acute illness.
If information was recorded concerning difficulties at work it
was included in the data analyses. Data on the infecting
serogroup were deduced from the serovar giving the highest
titers in the MAT [14]. Common complaints were classified as
separate variables in the database. Data was collected on liver
injury, haemorrhage, acute renal injury (ARI) and acute lung
injury (ALI). WHO-LERG definitions were used for ARI and ALI
[2]. In brief, ALI patients presents with respiratory distress
indicated by dyspnoea and/or a respiratory frequency ≥28 per
minute, bilateral crepitus, bilateral infiltrates in chest X-ray
examination, a ratio of the partial pressure of arterial oxygen to
the fraction of inspired oxygen (PaO2/FiO2) <300mm or report
of the use of mechanical ventilation as a therapeutic
intervention. ARI is defined by an acute onset of oliguria,
uraemia, or abnormally elevated serum creatinin or blood urea
nitrogen. Liver injury is defined by jaundice, hepatitis and/or
abnormal laboratory findings with respect to blood albumin
and/or bilirubin, alanine-aminotransferase (ALAT or SGPT),
aspartate-aminotransferase (ASAT or SGOT) and/or lactate
dehydrogenase (LDH), alkaline phosphatase and γ-glutamyl
transpeptidase (γ-gt). The term ‘haemorrhage’ refers to a
recorded bleeding such as petechiae and gastrointestinal
bleeding.
Data analysis
Descriptive data is presented on the duration of acute illness,
the presence of complaints after discharge from the hospital in
the CPC group and presence, nature and duration of
complaints in the PCAC group using median (IQR) and
proportions. Mann Whitney tests were conducted to determine
differences in duration of acute illness by age and sex. Chi-
square tests and fisher’s exact tests were used to assess the
association between reported complaints by age, gender,
infecting serogroup and occurrence of the acute severe
complications ALI, ARI, liver injury and haemorrhage and ICU
stay.
Multivariate logistic regression analysis was performed to
assess risk factors for ICU stay. Variables were considered for
the multivariate model if it was associated with complaints and
ICU stay with a p<0.10. Associations are presented by Odds
Ratios (OR) with the corresponding 95% confidence intervals.
Analyses were conducted using SPSS software version 17.0.
Results
Incidence and duration of illness
During the period 1985 to 2010, 829 patients were confirmed
with leptospirosis; 764 (92.3%) males and 64 (7.7%) females
(Table 1). A total of 570 patients (78.9%) were known to be
hospitalized, 106 patients (of whom 13 died) were reported to
have been admitted to the ICU (Table 1). Reference to the ICU
has been poorly documented, but from those with recorded
data, ICU admission was usually within the first day of hospital
admission.
18 males and 1 female died during the recorded period
(Table 1). Based on available data of 369 (67%) of the 552
surviving hospitalized patients the median duration of total
acute phase of illness was 16 days (IQR 12–23 days). The
median duration of illness prior to hospital admission was 5
days and of hospital stay was 10 days. The median duration of
ICU stay was 7 days (Table 2).
Current policies in the Netherlands aim at reducing the
period of hospitalization. Consistently, in the years 2005 to
2010 the median duration of hospital attendance was lower (8
days IQR 6–11 days) compared to the entire period 1985-2010
(10 days; IQR 7–16 days) while the period ‘prior hospitalization’
remained virtually the same (median 4 days, IQR 3-7 days).
The median number of days prior to hospital admission did
not differ by age (<38 and ≥38 years) or gender. However,
males had a longer hospital stay compared to females (11
versus 7.5 day, p=0.013). Individuals aged ≥ 38 had longer
hospital stay (12 versus 9 days, p<0.001).
Factors associated with Complaints by Passive Case
finding (CPC)
Data was available on health status after discharge for 236
of the 552 hospitalized surviving patients, with a small
difference in age and gender of those with data available and
not available. The number of males in the included versus the
excluded cases was 213 (90.6%) and 295 (93.4%),
respectively and the median age was 37 years, (IQR 25-50) for
those included and 39 years, (IQR 26-54) for those excluded.
The number of CPC was 108 (45.8%) (Table 1). Individuals
of older age (≥ 38 years) were two times more likely to have
CPC compared to individuals of younger age (OR 2.2, 95%CI
1.3-3.7) (Table 3). Complaints typically comprised non-specific
aberrations noticed during physical examination during the
follow-up visit by physician, such as (extreme) fatigue,
headaches, hair loss at young age, mild jaundice and disability
to work and/or supported by abnormal laboratory findings. No
association was found between CPC and gender (males, OR
1.3, 95%CI 0.5-3.1) and the overall infecting serogroup (Table
3). However, subgroup analyses suggest that Sejroe group
infections (OR 4.8, 95% CI 0.9-27.0) and Icterohaemorrhagiae
group infections (OR 2.0, 95% CI 0.9-4.3) were more likely to
result in CPC compared to serogroup Grippotyphosa.
Remarkably, when taking ICU attendance as a marker for
severity of acute illness, Sejroe group infections caused milder
disease (none of 8 cases attended the ICU) compared to
Icterohaemorrhagiae group infections of whom 19% (17/89)
needed ICU care (data not shown). This might indicate a
potential effect by distinct serogroups on the occurrence of
CPC, apparently unrelated to case severity.
Factors associated with Persistent Complaints by
Active Case finding (PCAC)
In total 321 questionnaires were distributed of which 256
(79.8%) were returned. Data from 31 questionnaires were
excluded because the information provided was incomplete
(n=28) or contained conflicting data (n=3). This resulted in 225
The Burden of Severe Human Leptospirosis
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eligible participants’ questionnaires. The median age was 38
years (IQR 20-46 years) of which 214 were male (95.5%). This
is comparable to those participants excluded, i.e. 33 years
(23-46 years) and 88 males (91.7%), respectively.
The number of PCAC was 68 (30.2%), and for 65 (95.6%)
cases these persistent complaints were specified. Depression-
compatible complaints were most frequently reported, such as
extreme fatigue, headache and malaise, or complaints that
seemed to present persistence, such as myalgia and joint
pains (Table 1). Several participants reported back pain and
vertigo (3 (4.6%) patients, each), depression and concentration
problems (2 (3.1%) patients, each). One participant reported
sleep disorders and one reported severe mental alterations. 27
of 65 participants (39.7%) reported ‘other symptoms’, this
Table 1. Patient characteristics of leptospirosis patients separated according to available data*.
Characteristic
Hospitalized and
outpatients  Hospitalized patients Hospitalized patients Hospitalized and outpatients
 
All laboratory confirmed
patients
Days of acute illness
known   
Health status after discharge
known; Complaints by
Passive Case Finding Group
Eligible questionnaires; Persistent
Complaints by Active Case finding
Group
period 1985-2010 1985-2010 1985-2010 1985-1993
n 829 369 236 225
Male† 764 (92.3) 332 (90.5) 213 (90.6) 214 (95.5)
Age - median (25th and 75th percentile) 38 (26-52) 38 (25-51) 37 (25-50) 38 (27-51)
Antibiotic treatment ** 653 (86.0) 327 (89.1) 205 (86.9) 171 (83.8)
Hospital admission# 570 (78.9) 368 (100) 236 (100) 129 (73.7)
Deceased no. (%)## 19 (2.3) 0 0 0
Dialysis on hospitalized patients†† 79 (16.1) 46 (12.7) 24 (10.2) 20 (17.9)
ICU admission*** 106 (21.3) 52 (14.5) 31 (13.4) 11 (10.3)
Serogroup known 676 298 192 205
 Missing 153 71 44 20
Icterohaemorrhagiae 312 (46.4) 154 (51.7) 92 (47.9) 84 (41.0)
Grippotyphosa 114 (16.9) 57 (19.1) 39 (20.3) 33 (16.1)
Sejroe 110 (16.3) 18 (6.0) 8 (4.2) 67 (32.7)
Pomona 56 (8.3) 28 (9.4) 18 (9.4) 14 (6.8)
Other serogroups 84 (12.4) 41 (13.8) 35 (18.2) 7 (3.4)
Post-leptospirosis complaints
Occurrence CPC NA NA 108 (45.8%) NA
Occurrence PCAC00 NA NA NA 68 (30.2%)
Extreme fatigue NA NA NA 44 (67.7%)
Myalgia NA NA NA 13 (20.0%)
Malaise NA NA NA 11 (16.9%)
Headaches NA NA NA 10 (15.4)
‘Hampered’ physical condition NA NA NA 10 (15.4%)
Joint complaints NA NA NA 6 (9.2%)
Disability to work NA NA NA 9 (13.8%)
Others NA NA NA 27 (41.5%)
Acute injuries
Period 1985-1993 1985-1993 1985-1993 1985-1993
n 332 125 62 225
ARI Yes 165 (61.8) 95 (78.5) 49 (83.1) 111 (59.7)
 No 102 (38.2) 26 (21.5) 10 (16.9) 75 (40.3)
 Missing 65 4 3 39
Haemorrhage Yes 62 (31.0) 36 (38.7) 19 (38.0) 43 (29.9)
 No 138 (69.0) 57 (61.3) 31 (62.0) 101 (70.1)
 Missing 132 32 12 81
Liver injury Yes 184 (80.7) 91 (81.3) 46 (80.7) 128 (79.5)
 No 44 (19.3) 21 (18.8) 11 (19.3) 33 (20.5)
 Missing 104 13 5 64
ALI Yes 27 (19.7) 15 (14.2) 7 (13.7) 15 (16.1)
 No 110 (80.3) 91 (85.8) 44 (86.3) 78 (83.9)
 Missing 195 19 11  132
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included typical thoracic pain, perspiration, painful shoulders,
stomach pain, and tinnitus.
The duration of PCAC was reported for 57 cases, 11 (19.3%)
cases reported ≤2 months, and 1 case reported 18-24 months
(Figure 1). However, 12 (21.1%) cases had chronic complaints
for more than 24 months. Difficulties in returning to work after
the acute phase of leptospirosis were reported in 9 out of 68
(13.2%) questionnaires, comprising the inability to work in a
dusty environment (1/9), disability to work for 2 months (2/9),
bed rest for 2 months (1/9), the need of assistance at the farm
for 6 months (1/9), increasing inability to do farmers work (1/9),
resigning the job because of disability of the associated labour
(1/9) and permanent disability to work (2/9).
Data in Table 3 show that higher age (≥38 years) was
positively associated with the occurrence of PCAC (OR 2.5,
95% CI 1.4-4.5), and males trended towards having more
complaints than females (OR 4.1, 95% CI 0.5-33.0), although
not significant. There was no association between age groups
and duration of PCAC or the type of symptoms, although
higher age showed a trend towards a higher proportion of
myalgia (OR 3.3, 95% CI 0.7-16.4) and physical condition
problems (OR 5.3, 95% CI 0.6-44.9).
ICU stay and persistent complaints
Univariate analysis revealed an increasing trend of post-
leptospirosis complaints associated with ICU attendance that
was significant for CPC (OR 2.8, 95%CI 1.3-6.3), Table 3.
Furthermore, it seemed ICU attendance and renal injuries
were not significantly associated with PCAC. Age was the only
risk factor significantly associated with PCAC, therefore only
univariate analyses were performed. This suggests that ICU
stay as well as the age of ≥ 38, dialysis and liver injury were
independently associated with an increase in the odds of
complaints (Table 3) in the CPC group but not in the PCAC
group.
No significant association was found between ARI, ALI and
haemorrhage and persistent complaints in both CPC and
PCAC groups (Table 3). Dialysis and age were retained in the
multivariate model to control for confounding (P<0.1). The
association between ICU stay and age in the univariate model
was 2.8 (95% CI 1.3-6.3); while in the multivariate model it was
2.0 (95% CI 0.8-4.8), Table 3. The odds ratio for dialysis
decreased from 3.2 (95% CI 1.3-8.0) in the univariate analysis
to 2.0 (95% CI 0.8-4.8) in multivariate analysis, suggesting
some confounding due to ICU stay and age.
Agreement between PCAC and CPC groups
The occurrence of persistent symptoms was assessed
through two methods, one using active case finding using
questionnaires and one using passive finding using routine
data from existing archive files. From 50 patients information
was available both on CPC and PCAC. When comparing data
from overlapping cases in both routes, results of CPC and
PCAC corroborated for 32 cases (64%), which implies a slight
agreement (Cohen’s kappa = 0.298). Fourteen of the 27 cases
Table 2. Days of acute illness of hospitalized, surviving
patients in the period 1985 to 2010, stratified according to
gender and age.
Duration in Category
Number of
patients
Median (25th and 75th
percentile) P-value*
Acute disease total 369 16 (12-23) NA
Males 333 16 (12-23) 0.018
Females 35 13 (9-21)  
Age <38 years 185 14 (11-19) <0.001
Age ≥38 years 187 19 (14-25)  
Prior hospitalization total 390 5 (3-7) NA
Males 352 5 (3-7) 0.735
Females 37 5 (2-7)  
Age <38 years 191 4 (3-7) 0.066
Age ≥38 years 199 5 (4-7)  
Hospitalization total 366 10 (7-16) NA
Males 331 11 (7-16) 0.013
Females 34 7.5 (6-12.5)  
Age <38 years 182 9 (6-13) <0.001
Age ≥38 years 184 12 (8-18)  
ICU attendance total 20 7 (4-13.5) NA
Males 19 7 (4-14) 0.223
Females 1 3  
Age <38 years 7 8 (3-12) 0.937
Age ≥38 years 13 13 (4-14.5)  
NA is Not applicable
* Mann Whitney test
doi: 10.1371/journal.pone.0076549.t002
Table 1 (continued).
NA Is Not Applicable
Values are no. (%) unless otherwise indicated
†. Sex was registered for 828 patients
**. Data on antibiotic treatment available from respectively 759/829, 367/368, 236/236 and 204/225 patients
Data on hospital admission available from respectively 722/829, 368/368, 236/236 and 175/225 patients
##. 18 Patients died in the hospital, 1 patient is unknown
††. Data on dialysis on hospitalized patients available from respectively 491/570, 361/368, 235/236 and 112/129 patients
***. Data on ICU admission on hospitalized patients available from respectively 497/570, 359/368, 231/236 and 107/122 patients
00 Symptoms for PCAC available for 65 cases
doi: 10.1371/journal.pone.0076549.t001
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with CPC (51.9%) reported prolonged complaints for 2 months
or more. On the other hand, four PCAC cases had no report on
CPC (S1).
Discussion
The main objective of this study was to estimate the burden
of human leptospirosis in the Netherlands with regard to the
Table 3. Uni- and multivariate analysis of risk factors for post-leptospirosis complaints.
Risk factors Available data within the risk categories CPC group OR 95%CI P value PCAC group OR 95%CI P value
Univariate analysis N=236 N=225
Sex Male 213 1.3 (0.5-3.1) 0.618° 214 4.1 (0.5-33.0) 0.289°°
 Female 22  10  
 Missing 1  1  
Age ≥38 years 117 2.2 (1.3-3.7) 0.003° 114 2.5 (1.4-4.5) 0.002°
 <38 years 119  111  
 Missing 0  0  
ICU Yes 31 2.8 (1.3-6.3) 0.009° 11 2.2 (0.6-8.0) 0.203°
 No 200  96  
 Missing 5  118  
Dialysis Yes 24 3.2 (1.3-8.0) 0.01° 20 1.2 (0.4-3.2) 0.763°
 No 211  92  
 Missing 1  17  
Serogroup Grippo 39 Reference 0.047° 33 Reference 0.827°
 Ictero 92 2.0 (0.9-4.3)  84 0.6 (0.3-1.5)  
 Sejroe 8 4.8 (0.9-27.0)  67 0.7 (0.3-1.7)  
 Pomona 18 0.6 (0.2-2.1)  14 1.0 (0.3-3.6)  
 Other 35 1.1 (0.4-2.7)  7 0.7 (0.1-4.2)  
 Unknown* 44  20  
Acute injuries (1985-1993) N=62 N=225
ARI Yes 49 1.0 (0.2-3.7) 0.612°° 111 1.6 (0.8-3.1) 0.171°
 No 10  75  
 Missing 3  39  
ALI Yes 7 1.5 (0.3-7.3) 0.703°° 15 1.1 (0.3-3.7) 0.580°°
 No 44  78  
 Missing 11  132  
Liver injury Yes 46 6.4 (1.2-33.0) 0.016° 128 1.2 (0.5-2.8) 0.658°
 No 11  33  
 Missing 5  64  
Haemorrhage Yes 19 0.7 (0.2-2.3) 0.608° 43 1.3 (0.6-2.7) 0.539°
 No 31  101  
 Missing 12  81  
Multivariate analysis N=236  N=225  
ICU stay Yes 31 2.0 (0.8-4.8) 0.112  NA
 No 200  
 Missing 5  
Age ≥38 years 117 2.0 (1.2-3.5) 0.010  NA
 <38 years 119  
Dialysis Yes 24 2.3 (0.9-6.2) 0.098  NA
 No 211  
 Missing 1  
The table presents data from the period 1985 till 2010, unless otherwise indicated
NA: not applicable
Ictero: icterohaemorrhagiae
Grippo: Grippotyphosa
° Chi-square test
°° Fisher’s exact test
Excluded from the analysis
doi: 10.1371/journal.pone.0076549.t003
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frequency and nature of post leptospirosis symptoms as well as
the duration of both the acute and persistent phase. In addition,
the effects of age, gender, severity of acute illness, including
ICU attendance and infecting serogroups were investigated as
potential risk factors on the occurrence of post-leptospirosis
complaints.
Dutch hospitalized patients had a median stay in the hospital
of 10 days and spend 5 days of illness before hospitalization.
The total duration of the acute phase thereby consisted of a
median 16 days. This concurs with previous data on the
duration of acute leptospirosis in the Netherlands and in other
parts of the world [3,15]. A limitation of this data is that it
concentrates on acute illness from severely ill patients
attending the hospital and therefore excludes less severe
cases, for which no hospital data were available. However,
hospitalization occurred in almost 80% of cases. Moreover,
less severe leptospirosis was recognized as such, suggesting a
relative high grade of severity for these cases (obviously,
patients did seek medical care and the clinician considered
leptospirosis), comparable or exceeding that of an influenza-
like disease. Taking into account that recovery from a severe
influenza-like disease usually requires one to two weeks,
ambulant cases are unlikely to considerably reduce the mean
duration of acute leptospirosis. Additionally, it is estimated that
at least 30% of severe patients in the Netherlands, are missed
due to unawareness or mis-diagnosis [3,16]. Denial of effective
treatment because of misdiagnosis probably results in a higher
severity of complications and a longer duration of illness [17]
and hence missed severe cases might well balance the
decrease in hospital days caused by ambulant cases.
The duration of hospital stay showed a declining trend
toward recent years. Although this does not exclude the
increase of less severe forms of leptospirosis, this more likely
reflects a general trend in the Netherlands aiming at the
reduction of time of hospital attendance [18–20]. This can be
partially explained by economic considerations in the
Netherlands and can partially be attributed to developments in
medical science and improved health awareness in the
population [17]. Thus the decline in duration of hospital stay
does not reflect a reduction of the burden of the acute phase of
disease but rather indicates that its definition based on
discharge of the hospital might become less appropriate.
Significant differences were found between the two age
categories, with older patients having a longer hospital stay
during the acute phase compared to younger patients. This is
in accordance with various reports that indicate that increasing
age is associated with increasing severity of leptospirosis [21].
This is not unique for leptospirosis but is commonly seen for a
variety of infectious diseases in the Netherlands (CBS).
Significant differences were also found between males and
females. Over 90% of the confirmed cases were male patients
and they spent more time in the hospital than their females
counterparts (11 versus 7.5 days). Similarly, the majority of ICU
cases were males (89/93) with a median ICU stay of 7 days.
This together indicates that males seem to acquire
leptospirosis more frequently and develop more severe
complications than females. This further substantiates earlier
reports that suggested that males are more susceptible to
severe leptospirosis than females [13,22]. The assessment of
the economic impact of the disease burden is beyond the
Figure 1.  Persistent complaints by active case finding (PCAC) stratified according to months of duration.  The bars
represent the percentage of the total of reported post-leptospirosis complaints separated according to duration, expressed in
periods of months as indicated on the X-axis.
doi: 10.1371/journal.pone.0076549.g001
The Burden of Severe Human Leptospirosis
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e76549
scope of this paper. However, it should be noted that the vast
majority (86%) of severe cases are male patients between 20
and 65 years of age, which is the current working age in the
Netherlands. Since females comprise less than 10% of those
presenting with leptospirosis, it is likely they will have little
effect on the national economic burden.
In 236 eligible participants from a total of 552 records
information was collected on persistent complaints in the first
month following the acute disease. This was most likely a
representative sample, since the median age and sex ratio was
comparable for those included and excluded cases. Nearly half
of these patients (45.8%) reported continuing complaints one
month after discharge from the hospital. This corroborates well
with a previous prospective study in Brazil, where complaints
were reported in 49% of former hospitalized patients at a follow
up of about 20 days [7].
The assessment of PCAC comprised a sample of 225
eligible participants from a total group of 321 patients, with a
comparable age and sex in the included and excluded groups.
PCAC occurred for one third of the patients with a declining
incidence towards a prolonged duration. However, one-fifth of
the PCAC patients had complaints that continued more than
two years. Complaints were generally depression-like
symptoms such as extreme fatigue, malaise, and headache.
Physical complaints included myalgia and joint pains affecting
mobility. In this sample, only a few files included information on
problems in executing ones job. However, it is well conceivable
that these depression-like conditions also impacted on the
ability to continue working and hence should be expected to
constitute a burden to DALYs.
The PCAC study group was conducted from 1985 to 1993
and was contained within the CPC study group. This allowed
for a comparison to investigate the association between the
two data sets used for these two groups. The presence or
absence of complaints was consistent for two-third of the
patients who had both PCAC and CPC data. About half of the
CPC group patients apparently had recovered from the post-
leptospirosis complaints since PCAC was not indicated.
However, for four PCAC group patients no CPC was
documented. This can be explained by assuming that either the
patients or the clinician considered CPC as normal at the
ambulant consultation and did not include the data in the
report. On the other hand, it is well conceivable that sequelae
develop after apparent complete cure from the acute illness as
has been reported for leptospirosis- related uveitis [23].
Evidence has consistently shown that serovars
Icterohaemorrhagiae and Copenhageni of the
Icterohaemorrhagiae group cause severe leptospirosis more
often than serovar Hardjo-bovis (Sejroe group) and serovar
Grippotyphosa (Grippotyphosa group) [12,14,24,25]. Assuming
that sequelae notably occur after traumatic and stressful acute
complications, one might expect to find persistent complaints
largely corroborating with Icterohaemorrhagiae as the infecting
serogroup. However, our data did not show any association
between any infecting serogroup and PCAC, although we
found an association compared to the Grippotyphosa
serogroup, albeit not significant, between CPC and infections
with the Icterohaemorrhagiae group. Surprisingly, however, this
association was more pronounced with Sejroe as the infecting
serogroup. These Sejroe infections are predominantly due to a
dairy fever outbreak caused by serovar Hardjo-bovis in the
period 1985-1995 [14]. Since complications requiring ICU
attendance apparently were absent, we argue that Sejroe
group infections cause less severe forms of leptospirosis.
Thus, while there seems to be a correlation between the
causative infection serotype and severity of illness on one
hand, this is not the case between disease severity and the
occurrence of persistent complaints on the other hand.
Consistently, delayed physical and psychological recovery after
Hardjo infection, taking several months to more than a year
have been reported by others [26]. Research among randomly
selected dairy farms in 1986 and 1987 showed that 63% of
persons seropositive for leptospirosis suffered from prolonged
excessive fatigue, which led to a partial or complete disability to
work [27]. Taking these arguments together, we conclude that
less severely ill dairy fever patients do have a relatively high
risk for persistent complaints. The reason for this remains
unclear, although it is tempting to speculate that the host-
dependence of the serovar Hardjo [28] is associated with a
greater invasive power of the central nervous system and/or
induces other pathways in the host defence responses.
ICU stay is considered to be a traumatic cause of long
lasting sequelae [8,9,11,29–31]. In concordance with this, ICU
patients had about a twice-higher risk for persistent complaints
that was significant for CPC. The risk even increased nearly a
12-fold when combined with dialysis as another stressful event
[32].
Although data on the duration of acute leptospirosis and
hospital and ICU stay have been presented in previous studies,
these are scarce [3]. Hence, the data on incidence, duration of
disease and the occurrence of persistent complaints assessed
in this paper present a valuable contribution to the current
initiatives to estimate the global burden of leptospirosis (WHO-
LERG) [2].
This study has some caveats. Numbers, notably of ICU stay
and of female cases are low and affect the statistical analyses
robustness. Additionally, too few data on the length of ICU stay
were available for adequately examining the association ICU
stay and PCAC. Although the severity of illness was assessed
by analysing several reliable indicators, such as ICU stay,
dialysis, ALI and ARI, this study did not use a ‘severity of
illness scoring system’ such as APACHE II score or SAPS
score [31]. Finally, and probably most importantly, data on
sequelae are based on persistent complaints after acute
leptospirosis. This does not necessarily imply that these can be
fully attributed to leptospirosis. Indeed, persistent complaints
also have been reported for other infectious diseases and thus
are not unique to leptospirosis. Uniqueness of persistent or
chronic symptoms can only be made plausible when including
a proper control group, which was not part of this study.
Moreover, sequelae, generally consisting of depression-like
symptoms, need to be corrected for similar complaints in the
whole population in order to clarify that a proportion of the
sequelae indeed can be exclusively attributed to the acute
disease. We have addressed this point by consulting national
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databases on population-wide trends in health and lifestyle
[33].
Compared to the persistent leptospirosis (CPC and PCAP of
45.8% and 30.2% respectively) the baseline data were much
lower, i.e. 18.5% of the general Dutch population did not have
a good health with several minor complaints summarized as
malaise and likely only for part constitute complaints with a
severity that has been reported for persistent leptospirosis.
Additionally, there is little correlation between malaise
complaints and age in the general population [33], while for
leptospirosis such complaints increase with increasing age.
Therefore, it is concluded that acute leptospirosis induces
persistent and late sequelae that contribute to the disease
burden. Reports on chronic leptospirosis usually concern
anecdotic case reports. This is one of the few, if not first,
systematic reports on the burden of both acute and chronic
leptospirosis and as such forms a highly valuable contribution
to the assessment of its global burden.
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